Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. حسب Søren Egstrand (10906087)

Maximum IFN concentrations are decreased in severe patients. حسب Sonia T. Gazeau (21512764)

Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means. حسب Mohammad Bakhtiari (11838264)

Mechlorethamine gel causes epithelium thinning, epithelium-stroma separation, and decreased total stroma cell count. حسب Ana M. Sandoval-Castellanos (11611315)

Participants enrollment. حسب Chikondi Maluwa (20660522)

"…Attitude improved from 16.76 (93.1%) at baseline to 17.74 (98.6%) at the six-week mark. Similarly, the mean practice score rose from 25.24 (78.9%) at baseline to 27.42 (85.7%) at week six. …"

KAP assessment scores (n = 422). حسب Chikondi Maluwa (20660522)

"…Attitude improved from 16.76 (93.1%) at baseline to 17.74 (98.6%) at the six-week mark. Similarly, the mean practice score rose from 25.24 (78.9%) at baseline to 27.42 (85.7%) at week six. …"

Infection related impact of different <i>Schistosoma mansoni</i> strains on host pathology. حسب Tim A. Dannenhaus (19959583)

Flow of participants through the study. حسب Sedighe Esmaeilzadeh (21100668)

"…Melatonin also led to considerable improvements in specific PSQI domains including: a substantial increase in sleep duration and a marked reduction in sleep disturbances. Furthermore, melatonin significantly decreased sleep latency, exhibiting a large effect size, and contributed to a medium reduction in the use of sleep medications. …"

Demographic Characteristics of Participants. حسب Sedighe Esmaeilzadeh (21100668)

"…Melatonin also led to considerable improvements in specific PSQI domains including: a substantial increase in sleep duration and a marked reduction in sleep disturbances. Furthermore, melatonin significantly decreased sleep latency, exhibiting a large effect size, and contributed to a medium reduction in the use of sleep medications. …"

Effect of dilution factor and replicate number on the reproducibility of αSyn^D seed concentration estimates in PD (A-D) and DLB (E-H) brain homogenates by ED RT-QuIC ass... حسب Ankit Srivastava (742990)

Clinical and Imaging Characteristics of Posterior Scleritis in Children حسب Ayala Katzir (20605679)

"…Retinal nerve fiber layer (RNFL) was thickened in all examined eyes (mean±SD 136.2 ± 28.4 µm) at presentation and it significantly decreased with treatment (109.8 ± 8.2 µm two months later). …"

Data Sheet 1_Exploring long COVID in pediatric patients: clinical insights from a long COVID clinic.docx حسب Dina Kamel (22434430)

"…Overall symptom burden decreased significantly over time (p < 0.001). Vaccination status at baseline was not associated with difference in symptom duration on initial presentation (p = 0.4). …"

Effect size distribution and intersections of transcript usage response upon stimulation with <i>M</i>. <i>leprae</i> sonicate by T1R-free (LEP) and T1R-destined (T1R) leprosy pati... حسب Wilian Correa-Macedo (11813183)

Barnes maze testing in animals on post-injury day 1. حسب Ghaith A. Bahader (21387572)

Supplementary file 1_Effects of a personalized PERMA-based intervention on the mental health of junior high school students: a randomized clinical trial.docx حسب Lei Zhang (38117)

Image 4_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.tiff حسب Øystein Fluge (200378)

"…Four patients had no significant clinical changes. Six patients experienced marked improvement. …"

Image 2_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.tiff حسب Øystein Fluge (200378)

"…Four patients had no significant clinical changes. Six patients experienced marked improvement. …"

Image 3_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.tiff حسب Øystein Fluge (200378)

"…Four patients had no significant clinical changes. Six patients experienced marked improvement. …"

Table 1_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.xlsx حسب Øystein Fluge (200378)

"…Four patients had no significant clinical changes. Six patients experienced marked improvement. …"

Image 1_Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study.tiff حسب Øystein Fluge (200378)

"…Four patients had no significant clinical changes. Six patients experienced marked improvement. …"